Please confirm the total number of referrals to the Trust’s lipid clinic during the financial years: 2010/11, 2011/12, 2012/13, 2013/14, 2014/15 and 2015/16.
| Year | All referrals |
| 11/12 | 1,325 |
| 12/13 | 1,658 |
| 13/14 | 1,548 |
| 14/15 | 1,365 |
| 15/16 | 1,517 |
| 16/17 | 1,608 |
Please confirm the total number of referrals to the Trust’s lipid clinics from (a) general practice and (b) secondary care during the financial years: 2010/11, 2011/12, 2012/13, 2013/14, 2014/15 and 2015/16.
| Year | GP referrals |
| 11/12 | 1,241 |
| 12/13 | 1,212 |
| 13/14 | 1,252 |
| 14/15 | 1,148 |
| 15/16 | 1,247 |
| 16/17 | 1,315 |
| Year | Secondary referrals |
| 11/12 | 82 |
| 12/13 | 126 |
| 13/14 | 235 |
| 14/15 | 216 |
| 15/16 | 260 |
| 16/17 | 293 |
- Secondary referral source includes:
| Following an Accident And Emergency Attendance |
| Following an Emergency Admission |
| Following an MDT Meeting |
| Inter-Provider New Pathway |
| Other Consultant – Different Condition |
| Other Consultant – Same Condition |
| Referral from an A&E Department |
| Specialist Nurse |
Please confirm the average waiting time between patient referral and appointment to the Trust’s lipid clinic during the financial years: 2010/11, 2011/12, 2012/13, 2013/14, 2014/15 and 2015/16.
| Financial Year | Average of weeks |
| 2010/11 | 5 |
| 2011/12 | 5 |
| 2012/13 | 4 |
| 2013/14 | 5 |
| 2014/15 | 8 |
| 2015/16 | 7 |
| 2016/17 | 9 |
Clinics included are,
- New Chemical Pathology (Lipids) Outpatients
- DBS Lipid Service Outpatients – Birmingham Heartlands Hospital
- DBS Lipid Service Outpatients Good Hope Hospital
- New Lipid Research
- New Chemical Pathology (Lipids) OP
Please confirm the proportion of patients accessing the Trust’s lipid clinic that are meeting their lipid targets during the financial years: 2010/11, 2011/12, 2012/13, 2013/14, 2014/15 and 2015/16.
We do not hold this information.
Please confirm the proportion of high risk cardiovascular disease patients* accessing the Trust’s lipid clinic that are routinely offered a structured annual review during the financial years: 2010/11, 2011/12, 2012/13, 2013/14, 2014/15 and 2015/16.
100%
Please confirm or deny whether the Trust has in place an integrated care pathway or clinical management strategy for the management of high risk cardiovascular disease patients. If confirmed, please provide details.
We can confirm that we do have a clinical management strategy. NICE 2014 CG181
Please state the budget allocated by the Trust to its lipid clinic during the financial years: 2010/11, 2011/12, 2012/13, 2013/14, 2014/15 and 2015/16.
*High risk of cardiovascular disease is defined as a history of any of the following: acute coronary syndrome (such as myocardial infarction or unstable angina requiring hospitalisation), coronary or other arterial revascularisation procedures, chronic heart disease, ischaemic stroke, peripheral arterial disease. [1]
We do not hold this information.
